ToI podcast

Daily Briefing Sept. 5: Research on brain tumors, COVID shots and car charge tech

Environmental reporter Sue Surkes discusses the Bazan deal and news for electric cars; health writer Nathan Jeffay looks at a groundbreaking brain cancer study, vaccine donations

Welcome to The Times of Israel’s Daily Briefing, your 15-minute audio update on what’s happening in Israel, the Middle East and the Jewish world, from Sunday through Thursday.

Environmental reporter Sue Surkes and health writer Nathan Jeffay join host Jessica Steinberg for today’s podcast.

Jeffay discusses the Israeli research that has identified and destroyed the power source of brain cancer in mice.

Surkes reviews the latest in the future sale of Bazan, the Oil Refineries company that has long dominated and polluted the Haifa skyline.

Jeffay talks about the use of game theory by Israeli researchers to determine whether it makes sense for countries to give their surplus coronavirus vaccine doses to other countries in need.

Finally, Surkes explains Zooz, an Israeli company’s fast electric car chargers being deployed in the US, Europe and Israel.

Discussed articles include:

Brain tumors vanish in mice after Israeli study finds and destroys ‘power source’

Polluting Haifa oil refineries must close by 2025, PM’s economic adviser demands

Israeli study: Western powers can protect own people by donating COVID shots abroad

Israeli systems that charge electric vehicles in 15 minutes to deploy in Europe, US

Subscribe to The Times of Israel Daily Briefing on iTunesSpotifyPlayerFM, Google Play, or wherever you get your podcasts.

Check out yesterday’s Daily Briefing episode:

 

Most Popular
read more:
If you’d like to comment, join
The Times of Israel Community.
Join The Times of Israel Community
Commenting is available for paying members of The Times of Israel Community only. Please join our Community to comment and enjoy other Community benefits.
Please use the following structure: example@domain.com
Confirm Mail
Thank you! Now check your email
You are now a member of The Times of Israel Community! We sent you an email with a login link to . Once you're set up, you can start enjoying Community benefits and commenting.